Find clinical trials for Breast Cancer in Montréal, QC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Montréal, QC, CAN:
ZetaMet™ is indicated for patients with destructive, lytic lesions due to metastatic breast cancer to bone, with or without involve...
Phase 2
Montréal, Quebec, Canada and 1 other location
DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...
Phase 1, Phase 2
Montreal, Quebec, Canada and 71 other locations
look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...
Phase 3
Montreal, Canada and 145 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
St-Jerome, Quebec, Canada and 317 other locations
postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...
Phase 2
Montréal, Quebec, Canada and 50 other locations
ribociclib and standard adjuvant endocrine therapy (ET) on invasive breast cancer-free survival (iBCFS), in a close to clinical pra...
Phase 3
Montreal, Quebec, Canada and 65 other locations
medicines for the potential treatment of advanced or metastatic breast cancer.This study is seeking participants who have breast...
Phase 1, Phase 2
Montreal, Quebec, Canada and 35 other locations
medicines for the potential treatment of advanced or metastatic breast cancer.This study is seeking participants who have breast...
Phase 1, Phase 2
Montreal, Quebec, Canada and 28 other locations
in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple negative breast...
Phase 1, Phase 2
Montreal, Quebec, Canada and 31 other locations
with inoperable or metastatic HR-positive, HER2- negative breast cancer who have been treated with one or two prior lines of...
Phase 3
Montreal, Quebec, Canada and 166 other locations
Clinical trials
Research sites
Resources
Legal